Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma

Figure 3

Dose-dependent cell cycle perturbation in Type II EC cell lines with HCI2509 treatment. (A, B) Cell cycle populations of (A) AN3CA and (B) KLE cell lines after exposure to vehicle, 300 nM, 1 μM, and 3 μM HCI2509 for 48 hours. 2 × 104 counts and 1 × 104 counts were used for AN3CA and KLE cells, respectively. Data is representative of four biological replicates. Mean and standard deviation are plotted (* p < 0.05, ** p < 0.01).

Back to article page